{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:16:42Z","timestamp":1789669002081,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12035-023-03578-3","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T21:02:07Z","timestamp":1692392527000},"page":"212-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Non-invasive Biomarkers for Early Detection of Alzheimer\u2019s Disease: a New-Age Perspective"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-6251","authenticated-orcid":false,"given":"Niyamat M. A.","family":"Chimthanawala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Haria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Sathaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"3578_CR1","first-page":"18","volume":"6","author":"L Samhan","year":"2022","unstructured":"Samhan L, Alfarra A, Abu-Naser SS, Amassi I (2022) Classification of Alzheimer\u2019s disease using convolutional neural networks. Int J Acad Inf Syst Res (IJAISR) 6:18\u201323","journal-title":"Int J Acad Inf Syst Res (IJAISR)"},{"key":"3578_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CEI, Vollset SE et al (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"key":"3578_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 7:e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"3578_CR4","doi-asserted-by":"publisher","unstructured":"Jahn H (2013) Memory loss in Alzheimer\u2019s disease. In: Dialogues in Clin Neurosci 445\u2013454. https:\/\/doi.org\/10.31887\/DCNS.2013.15.4\/hjahn","DOI":"10.31887\/DCNS.2013.15.4\/hjahn"},{"issue":"6","key":"3578_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/mp.51.6.293","volume":"51","author":"L Tilley","year":"1998","unstructured":"Tilley L, Morgan KKN (1998) Reviews genetic risk factors in Alzheimer\u2019s disease. J Clin Pathol: Mol Pathol 51(6):293\u2013304. https:\/\/doi.org\/10.1136\/mp.51.6.293","journal-title":"J Clin Pathol: Mol Pathol"},{"issue":"8","key":"3578_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734\u2013746. https:\/\/doi.org\/10.1016\/S1474-4422(07)70178-3","journal-title":"Lancet Neurol"},{"issue":"3","key":"3578_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7(3):137\u2013152. https:\/\/doi.org\/10.1038\/nrneurol.2011.2","journal-title":"Nat Rev Neurol"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00770-2","volume":"13","author":"J Stockmann","year":"2021","unstructured":"Stockmann J, Verberk IMW, Timmesfeld N et al (2021) Correction to: Amyloid-\u03b2 misfolding as a plasma biomarker indicates risk for future clinical Alzheimer\u2019s disease in individuals with subjective cognitive decline (Alzheimer\u2019s Research & Therapy, (2020), 12, 1, (169). 10.1186\/s13195-020-00738-8). Alzheimers Res Ther 13:1\u201313. https:\/\/doi.org\/10.1186\/s13195-021-00770-2","journal-title":"Alzheimers Res Ther"},{"key":"3578_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/dnnd.s228939","volume":"9","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Langerman H (2019) Alzheimer\u2019s disease \u2013 why we need early diagnosis. Degener Neurol Neuromuscul Dis 9:123\u2013130. https:\/\/doi.org\/10.2147\/dnnd.s228939","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"3578_CR10","doi-asserted-by":"publisher","DOI":"10.2210\/rcsb_pdb\/mom_2006_7","author":"DS Goodsell","year":"2006","unstructured":"Goodsell DS (2006) Amyloid-beta precursor protein. RCSB Protein Data Bank. https:\/\/doi.org\/10.2210\/rcsb_pdb\/mom_2006_7","journal-title":"RCSB Protein Data Bank"},{"key":"3578_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jnc.12202","volume":"126","author":"L Gu","year":"2013","unstructured":"Gu L, Guo Z (2013) Alzheimer\u2019s A\u03b242 and A\u03b240 peptides form interlaced amyloid fibrils. J Neurochem 126:305\u2013311. https:\/\/doi.org\/10.1111\/jnc.12202","journal-title":"J Neurochem"},{"key":"3578_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1208\/s12248-014-9682-8","volume":"17","author":"SK Fischer","year":"2015","unstructured":"Fischer SK, Joyce A, Spengler M et al (2015) Emerging technologies to increase ligand binding assay sensitivitY. AAPS J 17:93\u2013101. https:\/\/doi.org\/10.1208\/s12248-014-9682-8","journal-title":"AAPS J"},{"key":"3578_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12745","author":"L Beyer","year":"2022","unstructured":"Beyer L, Stocker H, Rujescu D et al (2022) Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer\u2019s disease diagnosis within 17 years. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12745","journal-title":"Alzheimers Dement"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"key":"3578_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/awaa399","volume":"144","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Grothe MJ, Ashton NJ et al (2021) Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum. Brain 144:325\u2013339. https:\/\/doi.org\/10.1093\/brain\/awaa399","journal-title":"Brain"},{"key":"3578_CR16","doi-asserted-by":"publisher","unstructured":"Wang YL, Chen J, Du ZL et al (2021) Plasma p-tau181 level predicts neurodegeneration and progression to Alzheimer\u2019s dementia: a longitudinal study. Front Neurol 12:. https:\/\/doi.org\/10.3389\/fneur.2021.695696","DOI":"10.3389\/fneur.2021.695696"},{"key":"3578_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/JEM.20200861","volume":"217","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Horie K, Sato C, Bateman RJ (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease. J Exp Med 217:1\u201312. https:\/\/doi.org\/10.1084\/JEM.20200861","journal-title":"J Exp Med"},{"key":"3578_CR18","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA et al (2020) Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain 143:3793\u20133804. https:\/\/doi.org\/10.1093\/brain\/awaa342","journal-title":"Brain"},{"key":"3578_CR19","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","volume":"269","author":"G Giacomucci","year":"2022","unstructured":"Giacomucci G, Mazzeo S, Bagnoli S et al (2022) Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in Subjective Cognitive Decline and Mild Cognitive Impairment. J Neurol 269:4270\u20134280. https:\/\/doi.org\/10.1007\/s00415-022-11055-5","journal-title":"J Neurol"},{"key":"3578_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20163979","volume":"20","author":"S Silvestro","year":"2019","unstructured":"Silvestro S, Bramanti P, Mazzon E (2019) Role of miRNAs in Alzheimer\u2019s disease and possible fields of application. Int J Mol Sci 20:1\u201326. https:\/\/doi.org\/10.3390\/ijms20163979","journal-title":"Int J Mol Sci"},{"key":"3578_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5","journal-title":"Cell"},{"key":"3578_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.03.004","volume":"156","author":"MJ Millan","year":"2017","unstructured":"Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer\u2019s disease: an integrative review. Prog Neurobiol 156:1\u201368. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.03.004","journal-title":"Prog Neurobiol"},{"key":"3578_CR23","doi-asserted-by":"publisher","unstructured":"Serpente M, Fenoglio C, D\u2019Anca M et al (2020) MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer\u2019s disease. Cells 9:. https:\/\/doi.org\/10.3390\/cells9061443","DOI":"10.3390\/cells9061443"},{"key":"3578_CR24","doi-asserted-by":"publisher","unstructured":"Liu Y, Xu Y, Yu M (2022) MicroRNA-4722\u20135p and microRNA-615\u20133p serve as potential biomarkers for Alzheimer\u2019s disease. Exp Ther Med 23:. https:\/\/doi.org\/10.3892\/etm.2022.11166","DOI":"10.3892\/etm.2022.11166"},{"key":"3578_CR25","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41380-021-01351-3","volume":"27","author":"R Wang","year":"2022","unstructured":"Wang R, Chopra N, Nho K et al (2022) Human microRNA (miR-20b-5p) modulates Alzheimer\u2019s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer\u2019s biomarkers. Mol Psychiatry 27:1256\u20131273. https:\/\/doi.org\/10.1038\/s41380-021-01351-3","journal-title":"Mol Psychiatry"},{"key":"3578_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-19862-6","volume":"12","author":"C Pe\u00f1a-Bautista","year":"2022","unstructured":"Pe\u00f1a-Bautista C, Tarazona-S\u00e1nchez A, Braza-Boils A et al (2022) Plasma microRNAs as potential biomarkers in early Alzheimer disease expression. Sci Rep 12:1\u201310. https:\/\/doi.org\/10.1038\/s41598-022-19862-6","journal-title":"Sci Rep"},{"issue":"2","key":"3578_CR27","first-page":"59","volume":"27","author":"R Sabry","year":"2020","unstructured":"Sabry R, El Sharkawy RE, Gad NM (2020) MiRNA -483\u20135p as a potential noninvasive biomarker for early detection of Alzheimer\u2019s disease. Egypt J Immunol 27(2):59\u201372","journal-title":"Egypt J Immunol"},{"key":"3578_CR28","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.18632\/oncotarget.15109","volume":"8","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj S, Laskowska-Kaszub K, Debski KJ et al (2017) Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects. Oncotarget 8:16122\u201316143. https:\/\/doi.org\/10.18632\/oncotarget.15109","journal-title":"Oncotarget"},{"issue":"12","key":"3578_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40263-017-0483-3","volume":"31","author":"A Ardura-Fabregat","year":"2017","unstructured":"Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A et al (2017) Targeting neuroinflammation to treat alzheimer\u2019s disease. CNS Drugs 31(12):1057\u20131082. https:\/\/doi.org\/10.1007\/s40263-017-0483-3","journal-title":"CNS Drugs"},{"key":"3578_CR30","doi-asserted-by":"publisher","unstructured":"Prins S, de Kam ML, Teunissen CE, Groeneveld GJ (2022) Inflammatory plasma biomarkers in subjects with preclinical Alzheimer\u2019s disease. Alzheimers Res Ther 14:. https:\/\/doi.org\/10.1186\/s13195-022-01051-2","DOI":"10.1186\/s13195-022-01051-2"},{"key":"3578_CR31","doi-asserted-by":"publisher","unstructured":"Cristina d\u2019Abramo C, D\u2019Adamio L, Giliberto L (2020) Significance of blood and cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: sensitivity, specificity and potential for clinical use. In: Villa C (ed) Novel biomarkers in Alzheimer\u2019s disease. J Pers Med MDPI, pp 67\u2013106. https:\/\/doi.org\/10.3390\/jpm10030116","DOI":"10.3390\/jpm10030116"},{"key":"3578_CR32","doi-asserted-by":"publisher","unstructured":"Muramori F, Kobayashi K, Nakamura I (1998) A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer\u2019s disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 52:. https:\/\/doi.org\/10.1111\/j.1440-1819.1998.tb02706.x","DOI":"10.1111\/j.1440-1819.1998.tb02706.x"},{"key":"3578_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E et al (2021) Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry 11:1\u201310. https:\/\/doi.org\/10.1038\/s41398-020-01137-1","journal-title":"Transl Psychiatry"},{"key":"3578_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2019.00229","volume":"11","author":"AL Gross","year":"2019","unstructured":"Gross AL, Walker KA, Moghekar AR et al (2019) Plasma markers of inflammation linked to clinical progression and decline during preclinical AD. Front Aging Neurosci 11:1\u20139. https:\/\/doi.org\/10.3389\/fnagi.2019.00229","journal-title":"Front Aging Neurosci"},{"key":"3578_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, Touchard S, Leckey C et al (2019) Inflammatory biomarkers in Alzheimer\u2019s disease plasma. Alzheimers Dement 15:776\u2013787. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.007","journal-title":"Alzheimers Dement"},{"key":"3578_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.720167","volume":"13","author":"A Majeed","year":"2021","unstructured":"Majeed A, Marwick B, Yu H et al (2021) Ophthalmic biomarkers for Alzheimer\u2019s disease: a review. Front Aging Neurosci 13:1\u201317. https:\/\/doi.org\/10.3389\/fnagi.2021.720167","journal-title":"Front Aging Neurosci"},{"key":"3578_CR37","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV et al (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54:S204\u2013S217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","journal-title":"Neuroimage"},{"key":"3578_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH et al (2019) Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun 10:1\u201312. https:\/\/doi.org\/10.1038\/s41467-019-12242-1","journal-title":"Nat Commun"},{"key":"3578_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ophtha.2006.08.046","volume":"114","author":"DL Budenz","year":"2007","unstructured":"Budenz DL, Anderson DR, Varma R et al (2007) Determinants of normal retinal nerve fiber layer thickness measured by stratus OCT. Ophthalmology 114:1046\u20131052. https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.046","journal-title":"Ophthalmology"},{"key":"3578_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S, Turkyilmaz K, Anlar O et al (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58\u201361. https:\/\/doi.org\/10.1097\/WNO.0b013e318267fd5f","journal-title":"J Neuroophthalmol"},{"key":"3578_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3341\/kjo.2016.0118","volume":"31","author":"JY Kwon","year":"2017","unstructured":"Kwon JY, Yang JH, Han JS, Kim DG (2017) Analysis of the retinal nerve fiber layer thickness in alzheimer disease and mild cognitive impairment. Korean J Ophthalmol 31:548. https:\/\/doi.org\/10.3341\/kjo.2016.0118","journal-title":"Korean J Ophthalmol"},{"key":"3578_CR42","doi-asserted-by":"publisher","unstructured":"Lim JKH, Li Q-X, He Z et al (2016) The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci 10:. https:\/\/doi.org\/10.3389\/fnins.2016.00536","DOI":"10.3389\/fnins.2016.00536"},{"key":"3578_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.preteyeres.2011.06.003","volume":"30","author":"M Pircher","year":"2011","unstructured":"Pircher M, Hitzenberger CK, Schmidt-Erfurth U (2011) Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res 30:431\u2013451. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.06.003","journal-title":"Prog Retin Eye Res"},{"key":"3578_CR44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/JAD-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins RN, Villemagne V, Sohrabi HR et al (2018) Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies. J Alzheimers Dis 62:965\u2013992. https:\/\/doi.org\/10.3233\/JAD-171145","journal-title":"J Alzheimers Dis"},{"key":"3578_CR45","doi-asserted-by":"publisher","unstructured":"Mark NJA, Henrik I, Kaj Blennow Z et al (n.d.) Salivary biomarkers for alzheimer\u2019s disease and related disorders. Neurol Ther 8:. https:\/\/doi.org\/10.6084\/m9.figshare.9792335","DOI":"10.6084\/m9.figshare.9792335"},{"key":"3578_CR46","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-S\u00e1nchez M, Bartolome F, Antequera D et al (2020) Decreased salivary lactoferrin levels are specific to Alzheimer\u2019s disease. J Clean Prod 57:. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102834","DOI":"10.1016\/j.ebiom.2020.102834"},{"key":"3578_CR47","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/npp.2017.8","volume":"42","author":"C Guo","year":"2017","unstructured":"Guo C, Yang ZH, Zhang S et al (2017) Intranasal lactoferrin enhances \u03b1-secretase-dependent amyloid precursor protein processing via the ERK1\/2-CREB and HIF-1\u03b1 pathways in an Alzheimer\u2019s disease mouse model. Neuropsychopharmacology 42:2504\u20132515. https:\/\/doi.org\/10.1038\/npp.2017.8","journal-title":"Neuropsychopharmacology"},{"key":"3578_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy SS, Lynch C, Ermini F et al (2019) Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5:1\u201322. https:\/\/doi.org\/10.1126\/sciadv.aau3333","journal-title":"Sci Adv"},{"key":"3578_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/jad-200064","volume":"75","author":"MA Beydoun","year":"2020","unstructured":"Beydoun MA, Beydoun HA, Hossain S et al (2020) Clinical and bacterial markers of periodontitis and their association with incident all-cause and Alzheimer\u2019s disease dementia in a large national survey. J Alzheimers Dis 75:157\u2013172. https:\/\/doi.org\/10.3233\/jad-200064","journal-title":"J Alzheimers Dis"},{"key":"3578_CR50","doi-asserted-by":"publisher","first-page":"75499","DOI":"10.1039\/c6ra16802g","volume":"6","author":"Q Liang","year":"2016","unstructured":"Liang Q, Liu H, Li X, Zhang AH (2016) High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer\u2019s disease. RSC Adv 6:75499\u201375504. https:\/\/doi.org\/10.1039\/c6ra16802g","journal-title":"RSC Adv"},{"key":"3578_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JAD-161226","volume":"58","author":"A Yilmaz","year":"2017","unstructured":"Yilmaz A, Geddes T, Han B et al (2017) Diagnostic biomarkers of Alzheimer\u2019s disease as identified in saliva using 1H NMR-based metabolomics. J Alzheimers Dis 58:355\u2013359. https:\/\/doi.org\/10.3233\/JAD-161226","journal-title":"J Alzheimers Dis"},{"key":"3578_CR52","doi-asserted-by":"publisher","first-page":"10802","DOI":"10.1021\/ac3028307","volume":"84","author":"J Zheng","year":"2012","unstructured":"Zheng J, Dixon RA, Li L (2012) Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment. Anal Chem 84:10802\u201310811. https:\/\/doi.org\/10.1021\/ac3028307","journal-title":"Anal Chem"},{"key":"3578_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1089\/ars.2021.0177","volume":"36","author":"NG Rummel","year":"2022","unstructured":"Rummel NG, Butterfield DA (2022) Altered metabolism in Alzheimer disease brain: role of oxidative stress. Antioxid Redox Signal 36:1289\u20131305. https:\/\/doi.org\/10.1089\/ars.2021.0177","journal-title":"Antioxid Redox Signal"},{"key":"3578_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2217\/nnm.12.105","volume":"8","author":"U Tisch","year":"2013","unstructured":"Tisch U, Schlesinger I, Ionescu R et al (2013) Detection of Alzheimer\u2019s and Parkinson\u2019s disease from exhaled breath using nanomaterial-based sensors. Nanomedicine 8:43\u201356. https:\/\/doi.org\/10.2217\/nnm.12.105","journal-title":"Nanomedicine"},{"key":"3578_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dad2.12088","volume":"12","author":"S Emam","year":"2020","unstructured":"Emam S, Nasrollahpour M, Colarusso B et al (2020) Detection of presymptomatic Alzheimer\u2019s disease through breath biomarkers. Alzheimers Dement: Diagn, Assess Dis Monit 12:1\u20139. https:\/\/doi.org\/10.1002\/dad2.12088","journal-title":"Alzheimers Dement: Diagn, Assess Dis Monit"},{"key":"3578_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78031-9","volume":"10","author":"N Kurbatova","year":"2020","unstructured":"Kurbatova N, Garg M, Whiley L et al (2020) Urinary metabolic phenotyping for Alzheimer\u2019s disease. Sci Rep 10:1\u201317. https:\/\/doi.org\/10.1038\/s41598-020-78031-9","journal-title":"Sci Rep"},{"key":"3578_CR57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000509561","volume":"10","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Hirao Y, Kasuga K et al (2020) Urinary apolipoprotein C3 is a potential biomarker for Alzheimer\u2019s disease. Dement Geriatr Cogn Dis Extra 10:94\u2013104. https:\/\/doi.org\/10.1159\/000509561","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"3578_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000496100","volume":"9","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, Hirao Y, Kasuga K et al (2019) Molecular network analysis of the urinary proteome of Alzheimer\u2019s disease patients. Dement Geriatr Cogn Dis Extra 9:53\u201365. https:\/\/doi.org\/10.1159\/000496100","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"3578_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep19495","volume":"6","author":"BA Kimball","year":"2016","unstructured":"Kimball BA, Wilson DA, Wesson DW (2016) Alterations of the volatile metabolome in mouse models of Alzheimer\u2019s disease. Sci Rep 6:1\u20138. https:\/\/doi.org\/10.1038\/srep19495","journal-title":"Sci Rep"},{"key":"3578_CR60","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1021\/acs.jproteome.7b00206","volume":"16","author":"J Yu","year":"2017","unstructured":"Yu J, Kong L, Zhang A et al (2017) High-throughput metabolomics for discovering potential metabolite biomarkers and metabolic mechanism from the APPswe\/PS1dE9 transgenic model of Alzheimer\u2019s disease. J Proteome Res 16:3219\u20133228. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00206","journal-title":"J Proteome Res"},{"key":"3578_CR61","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V et al (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93:e1647\u2013e1659. https:\/\/doi.org\/10.1212\/WNL.0000000000008081","journal-title":"Neurology"},{"key":"3578_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, el Khoury J et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03578-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:27:45Z","timestamp":1705379265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03578-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03578-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}